Journal Report

NUCLEIC ACID THERAPEUTICS

Download PDF
Journal Information
Journal Title
NUCLEIC ACID THERAPEUTICS
Publisher
SAGE PUBLICATIONS INC
ISSN
2159-3337
E-ISSN
2159-3345
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Nucleic Acid Therapeutics in an Age of Artificial Intelligence
David R. Corey
2026-10-15
DOI: 10.1177/21593337261496161
Antisense Oligonucleotides that Are Toxic to Prion-Infected Mice Share an Emergent Mechanism
Hien T. Zhao, Jill O’Moore, Daniel A. Sprague et al.
2026-10-10
DOI: 10.1177/21593337261494829
Nonclinical Development of Oligonucleotide-Based Therapeutics: Insights from an IQ DruSafe ONT Working Group Survey
Tod A. Harper Jr, Yi Yang, Sucheta Mukherjee et al.
2026-10-8
DOI: 10.1177/21593337261494828
Incorporation of a pH-Sensitive Linker into Lipid–ASO Conjugates Drives Increased Endosomal Membrane Remodeling Events
Priyanka Mangla, Emma Kay, Michael J. Munson et al.
2026-9-22
DOI: 10.1177/21593337261488803
rHuPH20 Enhances Extravascular Delivery of mRNA Lipid Nanoparticles in Mice and Minipigs
Ryan P. Nolan, Marie A. Printz, David W. Kang et al.
2026-8-12
DOI: 10.1177/21593337261479163
Embryo–Fetal Development and Maternal–Fetal Exposure of the Von Willebrand Factor Binding Aptamer Rondaptivon Pegol (BT200) in Rabbits
Katarina D. Kovacevic Miljević, Shuhao Zhu, James C. Gilbert et al.
2026-8-11 Vol. 36 Issue 5 Pages 221-231
DOI: 10.1177/21593337261476421
Evaluation of Antisense Oligonucleotide-Associated Neuronal Lysosomal Changes
Albert A. Mondragon, Kirk W. Donovan, Xiaoping Hronowski et al.
2026-8-6 Vol. 36 Issue 5 Pages 232-243
DOI: 10.1177/21593337261473518
Biodistribution of Phosphorothioate-Based Antisense Oligonucleotides in Stabilin Receptor Knock-Out Models
Linda B. Pratt, Abby E. Bopp, Edward N. Harris
2026-8-3 Vol. 36 Issue 5 Pages 244-252
DOI: 10.1177/21593337261473078
Optimized Chemical Modifications Enhance Lipid Nanoparticle-Mediated siRNA Silencing of <i>YAP1</i> and <i>WWTR1</i>
Kaito Ueda, Tatsuki Sato, Jumpei Sasaki et al.
2026-7-21 Vol. 36 Issue 5 Pages 253-263
DOI: 10.1177/21593337261469503
Aptamers: Current Applications in Leukemia Diagnostics and Therapeutics
Bahareh Hosseinpour, Joshua O’Grady, Neda Mohaghegh et al.
2026-6-15 Vol. 36 Issue 4 Pages 187-201
DOI: 10.1177/21593337261458148
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 25, 2026 20:10